Episealer® clinical results accepted for presentation at the German Knee Society Congress
Episurf Medical (NASDAQ: EPIS B) today announces further progress on its important strategy of generating clinical results from the use of the Episealer® knee implant. The scientific abstract “Clinical results of an individualized mini-metal implant for focal cartilage lesions in the knee” by Johannes Holz, Tim Spalding, Karl Eriksson, Tobias Jung, Peter Verdonk and Clemens Kösters has been accepted for presentation at the 7th Annual Congress of the Deutschen Kniegesellschaft (DKG, the German Knee Society). The congress will take place in Munich on November 23-24, 2018. The abstract